Lamotrigine Compared with Lithium in Mania: A Double-Blind Randomized Controlled Trial

References

• Kotler M, Matar MA: Lamotrigine in the treatment of resis-tant bipolar disorder. Clin Neuropharmacol 1998; 21:65–67
   Google Scholar
• Sporn J, Sachs G: The anticonvulsant lamotrigine in treatment resistant manic depressive illness. J Clin Psychopharmacol 1997; 17:185–189
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Fatemi SH, Woyshville Ml: Antidepressant effects of lamotrigine in rapid cycling bipolar disorder. Am J Psychiatry 1996; 153:1236
   PubMed Web of Science ®Google Scholar
• Walden J, Hesslinger B, van Calker D, Berger M: Addition of lamotrigine to valproate may enhance efficacy in the treat-ment of bipolar disorder. Pharmacopsychiatry 1996; 29:193–195
   PubMed Web of Science ®Google Scholar
• Fogelson DL, Sternbach H: Lamotrigine treatment of refrac-tory bipolar disorder. J Clin Psychiatry 1997; 58:271–273
   PubMedGoogle Scholar
• Fatemi SH, Rappaport DJ, Calabrese JR, Thuras P: Lamotrig-Me in rapid cycling bipolar disorder. J Clin Psychiatry 1997; 58:12
   Google Scholar
• Kusumakar V, Yatham LN: Lamotrigine treatment of rapid cycling bipolar disorder. Am J Psychiatry 1997; 154:1171–1172
   PubMedGoogle Scholar
• Kusumakar V, Yatham LN: An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 1997; 72:145–148
   PubMed Web of Science ®Google Scholar
• Labbate LA, Rubey RN: Lamotrigine for treatment refractory bipolar disorder. Am J Psychiatry 1997; 154:1317
   Google Scholar
• Mandoki M: Lamotriginevalproate in treatment resistant bi-polar disorder in children and adolescents. Annual Meeting of the Society for Biological Psychiatry, San Diego, May 17 1997
   Google Scholar
• Ferrier IN: Lamotrigine and gabapentin. Alternatives in the treatment of bipolar disorder. Neuropsychobiology 1998; 38:192–197
   Google Scholar
• Calabrese J, Bowden C, McElroy S, Cookson J, Andersen J, Keck P, Rhodes L, Bolden-Watson C, Zhou J, Ascher J.: Spectrum of activity of lamotrigine in treatment refractory bipolar disorder. Am J Psychiatry 1999; 156:1019–1023
   Google Scholar
• Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD: A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depres-sion. Lamictal 602 Study Group. J Clin Psychiatry 1999; 60:79–88
   PubMed Web of Science ®Google Scholar
• Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J: Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disor-der. N Engl J Med 1989; 321:1489–1493
   PubMed Web of Science ®Google Scholar
• Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, Garza-Trevino ES, Risch SC, Goodnick PJ, Morris DD for the Depakote Mania Study Group: Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994; 271:918–924
   PubMed Web of Science ®Google Scholar
• Gilman JT: Lamotrigine: An antiepileptic agent for the treat-ment of partial seizures. Ann Pharmacother 1995; 29:144–151
   PubMed Web of Science ®Google Scholar
• Keck PE, McElroy SL, Strakowski SM: Anticonvulsants and antipsychotics in the treatment of bipolar disorder. J Clin Psychiatry 1998; 59:74–82
   PubMedGoogle Scholar
• Swann AC, Bowden CL, Morris D, Calabrese JR, Petty F, Small J, Dilsaver SC, Davis JM: Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psy-chiatry 1997; 54:37–42
   PubMed Web of Science ®Google Scholar
• Post RM, Uhde TW, Roy-Byrne PP, Joffe RT: Correlates of antimanic response to carbamazepine. Psychiatry Res 1987; 21:71–83
   PubMed Web of Science ®Google Scholar
• Schaffer CB, Schaffer LC: Gabapentin in the treatment of bipolar disorder. Am J Psychiatry 1997; 154:291–292
   PubMedGoogle Scholar
• Kaufman KR: Adjunctive tiagabine treatment of psychiatric disorders: Three cases. Ann Clin Psychiatry 1998; 10:181–184
   PubMedGoogle Scholar
• Calabrese JR, Shelton MD, Keck PE, et at.: Topiramate in severe treatment refractory mania. Poster presented at the APA annual meeting, Toronto; 1998
   Google Scholar
• McElroy SL, Kmetz GF, Keck PE: A pilot trial of adjunctive topiramate in the treatment of bipolar disorder. Poster pre-sented at the CINP, Glasgow; 1998
   Google Scholar
• Marcotte D, Gullick E: Use of topiramate, a new antiepileptic drug as a mood stabilizer. Poster presented at the CINP, Glasgow; 1998
   Google Scholar
• Stanton S, Keck PE Jr, McElroy SL: Treatment of acute mania with gabapentin. Am J Psych 1997; 154:287
   Google Scholar
• Schaffer CB, Schaffer LC: Gabapentin in the treatment of bipolar disorder [Letter]. Am J Psych 1997; 154:291–292
   PubMedGoogle Scholar
• McElroy SC, Soutullo CA, Keck PE Jr, et al.: A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann Clin Psychiatry 1997; 9:99–103
   Google Scholar
• Soutullo CA, Casuto LS, Keck PE Jr: Gabapentin in the treatment of adolescent mania: A case report. J Child Adolesc Psychopharmacol 1998; 8:81–85
   PubMedGoogle Scholar
• Knoll J, Stegman K, Suppes T: Clinical experience using gaba-pentin in patients with a history of mania or hypomania. J Affect Disord 1988; 49:229–233
   Google Scholar
• Kanaba S, Yagi G, Kamijima K, et at.: The first open study of zonisamide, a novel anticonvulsant shows efficacy in mania. Prog Neuropsychopharrnacol Biol Psychiatry 1994; 18:707–715
   Google Scholar